Is It Time to Anticipate the Use of PARP Inhibition in Prostate Cancer Patients?

The increasing diffusion of genetic analysis regarding the pathogenetic variants (PVs) of genes involved in DNA Damage Repair (DDR) mechanisms and the development of Poly ADP ribose polymerase (PARP) inhibitors (PARPis) led to the first valid precision medicine option tailored toward metastatic pros...

Descripción completa

Detalles Bibliográficos
Autores principales: Sciarra, Alessandro, Santarelli, Valerio, Santodirocco, Lorenzo, Frisenda, Marco, Salciccia, Stefano, Casale, Paolo, Forte, Flavio, Mariotti, Gianna, Moriconi, Martina, Cattarino, Susanna, Sciarra, Beatrice, Bevilacqua, Giulio, Gentilucci, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528501/
https://www.ncbi.nlm.nih.gov/pubmed/37754499
http://dx.doi.org/10.3390/curroncol30090584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10528501/
https://www.ncbi.nlm.nih.gov/pubmed/37754499
http://dx.doi.org/10.3390/curroncol30090584

Ejemplares similares